An angiogenic factor, platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP), stimulates the chemotaxis of endothelial cells and confers resistance to apoptosis induced by hypoxia. 2-Deoxy-D-ribose, a degradation product of thymidine generated by TP enzymatic activity, partially prevented hypoxia-induced apoptosis. TP was expressed at higher levels in tumor tissues compared to the adjacent non-neoplastic tissues in a variety of human carcinomas. High expression of TP is associated with an unfavorable prognosis. To investigate the eŠect of TP on cisplatin-induced apoptosis, human leukemia Jurkat cells were transfected with wild-type or mutant (L148R) TP cDNA. Jurkat cells transfected with TP cDNA (Jurkat/TP) and mutant TP cDNA (Jurkat/TPMu) expressed high levels of TP, while Jurkat/CV cells which were transfected with a control vector did not express TP. A high TP enzyme activity was detected in Jurkat/TP cells, but not in Jurkat/CV and Jurkat/TPMu cells. Sensitivities to cisplatin of these cells were determined by MTT assay. IC 50 values for cisplatin of Jurkat/CV, Jurkat/TP, and Jurkat/TPMu cells were 4.50, 14.08, 13.40 mM, respectively. Jurkat/TP and Jurkat/TPMu cells were about three times more resistant to cisplatin than Jurkat/CV cells. TP inhibited activation of caspase 3, 9 and mitochondrial cytochrome c release induced by cisplatin. Theseˆndings suggest a mechanism by which TP confers the resistance to cisplatin-induced apoptosis. Moreover, mutant TP that has no enzymatic activity also suppressed the cisplatin-induced apoptosis. These suggest that TP molecules have cytoprotective functions against cytotoxic agents.
Cells were lysed in buŠer A [25 mM Hepes (pH 7.4), 5 mM EDTA, 2 mM DTT, 2 mM p-aminophenylmethanesulfonyl‰uoride (APMSF), 10 mg/ml pepstatine A, and 10 mg/ml leupeptin]. The lysates were clariˆed by centrifugation and the supernatants were used for enzyme assays. Enzyme reactions were carried out in buŠer A containing 100 mg protein and 50 mM Ac-DEVD-7-amino-4-methylcoumarin (AMC), 50 mM Ac-LEHD-AMC or Ac-IETD-7-amino-4-tri‰uoromethylcou-marin (AFC) as substrates for caspase 3, 9 and 8, respectively. The reaction mixtures were incubated at 30°C for 60 min. Activities of caspases 3, 9 and 8 were determined by measuring the ‰uorescence intensity of AMC and AFC using a ‰uorescence reader. The eŠect of cisplatin on the activity of caspase 3, 9, and 8 in cells in Jurkat/CV and Jurkat/TP cells is shown. Jurkat/CV, Jurkat/TP, and Jurkat/TPMu cells were incubated in the presence of 10 mM cisplatin for 36 h. To determine the release of cytochrome c from mitochondria to cytosol, cytosolic fractions were prepared and subjected to immunoblot analysis using a speciˆc antibody against cytochrome c. To determine the levels of proteins attached to the mitochondrial membranes, mitochondrial fractions were prepared and subjected to immunoblot analysis using speciˆc antibodies against Bcl-2 and Bax. 
